Sami Shihabi is the Chief Commercial Officer at Progenity overseeing both the Women's Health and Precision Medicine business units. With 20+ years of experience in the healthcare industry, Sami's experience covers corporate strategy, product portfolio planning and commercialization, market expansions, and commercial development across the medical device, molecular diagnostics, and therapeutics industries.
Prior to joining Progenity, Sami was the Chief Commercial Officer at Prometheus Laboratories, a leader of precision healthcare in gastroenterology. He led the sales, marketing, and managed care organizations in addition to establishing the corporate and portfolio pipeline strategies. Prior to that, he led marketing at Valeant Pharmaceuticals for the hepatology and infectious diseases portfolio. Earlier in his career, he worked at Baxter Oncology in various roles spanning from R&D to sales and product management in the field of hematopoietic stem cell transplants for hematologic malignancies. Sami holds an MBA from UC Irvine and an MS in Molecular Biology from Penn State University.